| Identification | Back Directory | [Name]
2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID | [CAS]
956317-36-5 | [Synonyms]
EOS-61935
Suvorexant internate 1
Suvorexant Intermediate II
5-methyl-2-(triazol-2-yl)benzoic acid
2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID
5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid
Benzoic acid, 5-methyl-2-(2H-1,2,3-triazol-2-yl)-
5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic Acid
Suvorexant: 5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid
Suvorexant INT, 5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid
5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid (For suvorexant) | [EINECS(EC#)]
689-732-5 | [Molecular Formula]
C10H9N3O2 | [MDL Number]
MFCD18382679 | [MOL File]
956317-36-5.mol | [Molecular Weight]
203.197 |
| Chemical Properties | Back Directory | [Melting point ]
174-176℃ | [Boiling point ]
413℃ | [density ]
1.35 | [vapor pressure ]
0-0.001Pa at 20-70℃ | [Fp ]
204℃ | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
soluble in Methanol | [form ]
Solid:particulate/powder | [pka]
3.00±0.36(Predicted) | [color ]
White to Light yellow | [LogP]
0.3 | [Surface tension]
56.7mN/m at 1.552g/L and 21.7℃ |
| Hazard Information | Back Directory | [Uses]
5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid is mainly used as an intermediate in organic synthesis and medicinal chemistry. It is used in the synthesis of Suvorexant, an orexin antagonist drug used in the treatment of insomnia. |
|
|